Imran Rashid is a Cardiology physician.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics need a complete publication history and a confident author match. We omit them when either check fails. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Bristol Myers SquibbProgram year20252 paymentsResearch$26,876openpaymentsdata.cms.gov ↗
- Novartis Pharmaceuticals CorporationProgram year20251 payment
- Siemens Medical Solutions USA, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
84.2%Beta blocker19.5%Metoprolol Succinate54%Carvedilol25%Metoprolol Tartrate21%Part D≥21 patientsStatin13.5%Atorvastatin Calcium68%Rosuvastatin Calcium21%Pravastatin Sodium10%Part D<11 patients+ 10 more classes in this area
Blood & clotting
10.1%Factor Xa inhibitor4.4%Eliquis100%Part D<11 patientsVitamin K antagonist3.6%Warfarin Sodium100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
5.6%SGLT2 inhibitor5.6%Jardiance100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2022–2026 per NIH RePORTER. The latest:
- 3D Cine Magnetic Resonance Fingerprinting for Rapid Phenotyping of Cardiomyopathy
Case Western Reserve University
FY2026$602,449R01HL163030 - 3D Cine Magnetic Resonance Fingerprinting for Rapid Phenotyping of Cardiomyopathy
Case Western Reserve University
FY2025$614,744R01HL163030 - 3D Cine Magnetic Resonance Fingerprinting for Rapid Phenotyping of Cardiomyopathy
Case Western Reserve University
FY2024$646,399R01HL163030
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Martin Leon, MD
Columbia University Irving Medical Center
Scott Solomon, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”